← Back to Search

Psychotherapy

Group Interpersonal Psychotherapy for Postpartum Depression (OPTIMUM Trial)

N/A
Waitlist Available
Led By Vivian Polak, HBA BMSc MD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after 12 weeks of group ipt
Awards & highlights

OPTIMUM Trial Summary

This trial will test the effectiveness of group IPT delivered virtually to women in Ontario, Canada who have postpartum depression, compared to usual care.

Eligible Conditions
  • Postpartum Depression

OPTIMUM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after 12 weeks of group ipt
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after 12 weeks of group ipt for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depressive symptoms on Edinburgh Postpartum Depression scale
Depressive symptoms on Patient Health Questionnaire-9 (PHQ-9)
Secondary outcome measures
Acceptability
Anxiety
Functioning
+2 more

OPTIMUM Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group interpersonal psychotherapyExperimental Treatment1 Intervention
Group IPT consists of 12 weeks of virtually-delivered therapy by two co-therapists via Zoom to a group of 6-8 women. The 12 weeks consist of 15 sessions, with the first 12 sessions taking place twice weekly (acute phase) for 6 weeks and the last 3 sessions occurring every other week (maintenance phase) for 6 weeks.
Group II: Usual careActive Control1 Intervention
Usual care refers to any care that the women wish to access, and there are no limits on the women in either group. It may include, but is not limited to, the family physician, obstetrician, and/or midwife, participation in regional standard perinatal depression programming, private therapy, online therapies, medication, etc.

Find a Location

Who is running the clinical trial?

Hamilton Academic Health Sciences OrganizationOTHER
20 Previous Clinical Trials
4,740 Total Patients Enrolled
McMaster UniversityLead Sponsor
885 Previous Clinical Trials
2,598,217 Total Patients Enrolled
12 Trials studying Postpartum Depression
3,061 Patients Enrolled for Postpartum Depression
Vivian Polak, HBA BMSc MDPrincipal InvestigatorMcMaster University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial currently open to enrollment?

"Confirmed. Information accessible on the clinicaltrials.gov website affirms that this medical trial, first posted in December of 2020, is actively recruiting patients. 126 individuals are needed across 1 site to complete the study."

Answered by AI

What conclusions are expected to be drawn from participating in this research?

"The focal point of this trial, which involves 12 weeks of group IPT, is to track changes in depressive symptoms by way of Edinburgh Postpartum Depression Scale assessment. Additionally, the secondary objectives are monitoring post-treatment maternal-infant attachment with Postpartum Bonding scale (ranging from 0-125), functioning via Sheehan Disability Scale (0-30), and client satisfaction ratings on Client Satisfaction Questionnaire-8 (1-4)."

Answered by AI

How many participants are being monitored in this research endeavor?

"Affirmative. According to the documentation located on clinicaltrials.gov, this medical trial is in active recruitment mode. It was posted on December 21st 2020 and updated as recently as March 4th 2021 for 126 participants across only one site."

Answered by AI
~29 spots leftby May 2025